Search research articles
Contact Us
Filters
Showing results (71-80 of 196) with videos related to
Page
of 20
Sort By:
Acta Neuropathologica Communications
|
November 28, 2023
Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma
Kensuke Tateishi, Yohei Miyake, Taishi Nakamura, et al.
Neuro-Oncology
|
July 7, 2016
Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients
Kourosh Jafari-Khouzani, Franziska Loebel, Wolfgang Bogner, et al.
Journal of Neurosurgery
|
November 26, 2016
Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas
Matthew R Strickland, Corey M Gill, Naema Nayyar, et al.
Nature Communications
|
August 16, 2024
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas
Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia, et al.
Cancer Research
|
June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated Cytotoxicity
Kensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Journal of Neuro-Oncology
|
October 21, 2024
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design
Ethan A Wetzel, Amin I Nohman, Annie L Hsieh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2015
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
Ovidiu C Andronesi, Franziska Loebel, Wolfgang Bogner, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 27, 2021
In Vivo Absolute Metabolite Quantification Using a Multiplexed ERETIC-RX Array Coil for Whole-Brain MR Spectroscopic Imaging
Bijaya Thapa, Azma Mareyam, Jason Stockmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Cancers
|
July 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma
Masih Tazhibi, Eric P Grewal, Rishab Ramapriyan, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 196) with videos related to
Sort By:
Page
of 20
Acta Neuropathologica Communications
|
November 28, 2023
Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma
Kensuke Tateishi, Yohei Miyake, Taishi Nakamura, et al.
Neuro-Oncology
|
July 7, 2016
Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients
Kourosh Jafari-Khouzani, Franziska Loebel, Wolfgang Bogner, et al.
Journal of Neurosurgery
|
November 26, 2016
Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas
Matthew R Strickland, Corey M Gill, Naema Nayyar, et al.
Nature Communications
|
August 16, 2024
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas
Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia, et al.
Cancer Research
|
June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated Cytotoxicity
Kensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Journal of Neuro-Oncology
|
October 21, 2024
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design
Ethan A Wetzel, Amin I Nohman, Annie L Hsieh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2015
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
Ovidiu C Andronesi, Franziska Loebel, Wolfgang Bogner, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 27, 2021
In Vivo Absolute Metabolite Quantification Using a Multiplexed ERETIC-RX Array Coil for Whole-Brain MR Spectroscopic Imaging
Bijaya Thapa, Azma Mareyam, Jason Stockmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Cancers
|
July 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma
Masih Tazhibi, Eric P Grewal, Rishab Ramapriyan, et al.
Page
of 20